For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
186
views
145
references
 Top references
cited by
0
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
1 collections
    0
    shares
      88
      similar
       All similar

      One-Click Submission System Now Available for SO Preprints, learn more on how this works in our blog post and don't forget to check the video, too!

      scite_
      0
      0
      0
      0
      Smart Citations
      0
      0
      0
      0
      Citing PublicationsSupportingMentioningContrasting
      View Citations

      See how this article has been cited at scite.ai

      scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

       
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Current Understanding of ALS Onset, Progression and Treatments

      Preprint
      In review
      research-article
      Author(s):   1 , , 2
      Publication date (Electronic preprint):
      Journal: ScienceOpen Preprints
      Publisher: ScienceOpen
      Keywords: ALS, Amyotrophic Lateral Sclerosis , SOD, Neurodegenerative, TDP-43, Gene therapy, ageing, neuroinflammation, ASO, Clinical
      Bookmark

            Abstract

            Content

            Author and article information

            Journal
            Title: ScienceOpen Preprints
            Publisher: ScienceOpen
            Publication date (Electronic preprint): 8 November 2024
            Affiliations
            [1 ] Independent researcher;
            [2 ] Gothenburg University;
            Author notes
            Author information
            https://orcid.org/0000-0001-7009-9702
            https://orcid.org/0000-0002-4944-9824
            Article
            DOI: 10.14293/PR2199.001277.v1
            SO-VID: 0327638f-598b-49ac-a7ca-c87ec7818999
            License:

            This work has been published open access under Creative Commons Attribution License CC BY 4.0 , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com .

            History
            Date received : 8 November 2024
            Categories

            Data availability: All data generated or analysed during this study are included in this published article (and its supplementary information files).
            ScienceOpen disciplines: Biotechnology,Neurosciences
            Keywords: ALS,Amyotrophic Lateral Sclerosis ,SOD,Neurodegenerative,TDP-43,Gene therapy,ageing,neuroinflammation,ASO,Clinical

            References

            1. Chen Alice. PARP inhibitors: its role in treatment of cancer. Chinese Journal of Cancer. 463–471. 2011. Editorial Office of Chinese Journal of Cancer. [Cross Ref]

            2. Kachaner David, Génin Pierre, Laplantine Emmanuel, Weil Robert. Toward an integrative view of Optineurin functions. Cell Cycle. Vol. 11(15):2808–2818. 2012. Informa UK Limited. [Cross Ref]

            3. Lin Chien-Liang Glenn, Kong Qiongman, Cuny Gregory D, Glicksman Marcie A. Glutamate Transporter EAAT2: A New Target For The Treatment Of Neurodegenerative Diseases. Future Medicinal Chemistry. Vol. 4(13):1689–1700. 2012. Informa UK Limited. [Cross Ref]

            4. Zarei Sara, Carr Karen, Reiley Luz, Diaz Kelvin, Guerra Orleiquis, Altamirano PabloFernandez, Pagani Wilfredo, Lodin Daud, Orozco Gloria, Chinea Angel. A comprehensive review of amyotrophic lateral sclerosis. Surgical Neurology International. Vol. 6(1)2015. Scientific Scholar. [Cross Ref]

            5. Imbimbo BrunoP, Triaca Viviana, Imbimbo Camillo, Nisticò Robert. Investigational treatments for neurodegenerative diseases caused by inheritance of gene mutations: lessons from recent clinical trials. Neural Regeneration Research. Vol. 18(8)2023. Medknow. [Cross Ref]

            6. Vaz Sandra H., Pinto Sara, Sebastião Ana M., Brites Dora. Astrocytes in Amyotrophic Lateral SclerosisAmyotrophic Lateral Sclerosis. p. 35–54. 2021. Exon Publications. [Cross Ref]

            7. Arslanbaeva Liaisan, Bisaglia Marco. Activation of the Nrf2 Pathway as a Therapeutic Strategy for ALS Treatment. Molecules. Vol. 27(5)2022. MDPI AG. [Cross Ref]

            8. Chen Chen, Ding Xiufang, Akram Nimrah, Xue Song, Luo Shi-Zhong. Fused in Sarcoma: Properties, Self-Assembly and Correlation with Neurodegenerative Diseases. Molecules. Vol. 24(8)2019. MDPI AG. [Cross Ref]

            9. Le Gall Laura, Anakor Ekene, Connolly Owen, Vijayakumar Udaya, Duddy William, Duguez Stephanie. Molecular and Cellular Mechanisms Affected in ALS. Journal of Personalized Medicine. Vol. 10(3)2020. MDPI AG. [Cross Ref]

            10. Huang Ping, Chen Guangwei, Jin Weifeng, Mao Kunjun, Wan Haitong, He Yu. Molecular Mechanisms of Parthanatos and Its Role in Diverse Diseases. International Journal of Molecular Sciences. Vol. 23(13)2022. MDPI AG. [Cross Ref]

            11. Provasek Vincent E., Mitra Joy, Malojirao Vikas H., Hegde Muralidhar L.. DNA Double-Strand Breaks as Pathogenic Lesions in Neurological Disorders. International Journal of Molecular Sciences. Vol. 23(9)2022. MDPI AG. [Cross Ref]

            12. Juan Celia Andrés, Pérez de la Lastra José Manuel, Plou Francisco J., Pérez-Lebeña Eduardo. The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies. International Journal of Molecular Sciences. Vol. 22(9)2021. MDPI AG. [Cross Ref]

            13. Ghemrawi Rose, Khair Mostafa. Endoplasmic Reticulum Stress and Unfolded Protein Response in Neurodegenerative Diseases. International Journal of Molecular Sciences. Vol. 21(17)2020. MDPI AG. [Cross Ref]

            14. Pagano Giovanni, Aiello Talamanca Annarita, Castello Giuseppe, Cordero Mario, D'Ischia Marco, Gadaleta Maria, Pallardó Federico, Petrović Sandra, Tiano Luca, Zatterale Adriana. Current Experience in Testing Mitochondrial Nutrients in Disorders Featuring Oxidative Stress and Mitochondrial Dysfunction: Rational Design of Chemoprevention Trials. International Journal of Molecular Sciences. Vol. 15(11):20169–20208. 2014. MDPI AG. [Cross Ref]

            15. Fang Ton, Je Goun, Pacut Peter, Keyhanian Kiandokht, Gao Jeff, Ghasemi Mehdi. Gene Therapy in Amyotrophic Lateral Sclerosis. Cells. Vol. 11(13)2022. MDPI AG. [Cross Ref]

            16. Obrador Elena, Salvador-Palmer Rosario, López-Blanch Rafael, Dellinger Ryan W., Estrela José M.. NAD+ Precursors and Antioxidants for the Treatment of Amyotrophic Lateral Sclerosis. Biomedicines. Vol. 9(8)2021. MDPI AG. [Cross Ref]

            17. Carrera-Juliá Sandra, Moreno Mari Luz, Barrios Carlos, de la Rubia Ortí Jose Enrique, Drehmer Eraci. Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review. Frontiers in Physiology. Vol. 11:2020. Frontiers Media SA. [Cross Ref]

            18. Prasad Archana, Bharathi Vidhya, Sivalingam Vishwanath, Girdhar Amandeep, Patel Basant K.. Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis. Frontiers in Molecular Neuroscience. Vol. 12:2019. Frontiers Media SA. [Cross Ref]

            19. Kalmar Bernadett, Greensmith Linda. Cellular Chaperones As Therapeutic Targets in ALS to Restore Protein Homeostasis and Improve Cellular Function. Frontiers in Molecular Neuroscience. Vol. 10:2017. Frontiers Media SA. [Cross Ref]

            20. Duan Qing-Qing, Jiang Zheng, Su Wei-Ming, Gu Xiao-Jing, Wang Han, Cheng Yang-Fan, Cao Bei, Gao Xia, Wang Yi, Chen Yong-Ping. Risk factors of amyotrophic lateral sclerosis: a global meta-summary. Frontiers in Neuroscience. Vol. 17:2023. Frontiers Media SA. [Cross Ref]

            21. Poulin-Brière Amélie, Rezaei Edris, Pozzi Silvia. Antibody-Based Therapeutic Interventions for Amyotrophic Lateral Sclerosis: A Systematic Literature Review. Frontiers in Neuroscience. Vol. 15:2021. Frontiers Media SA. [Cross Ref]

            22. Abramzon Yevgeniya A., Fratta Pietro, Traynor Bryan J., Chia Ruth. The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Frontiers in Neuroscience. Vol. 14:2020. Frontiers Media SA. [Cross Ref]

            23. Berning Britt A., Walker Adam K.. The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD. Frontiers in Neuroscience. Vol. 13:2019. Frontiers Media SA. [Cross Ref]

            24. Khalid Syed I., Ampie Leonel, Kelly Ryan, Ladha Shafeeq S., Dardis Christopher. Immune Modulation in the Treatment of Amyotrophic Lateral Sclerosis: A Review of Clinical Trials. Frontiers in Neurology. Vol. 8:2017. Frontiers Media SA. [Cross Ref]

            25. Kotliarova Anastasiia, Sidorova Yulia A.. Glial Cell Line-Derived Neurotrophic Factor Family Ligands, Players at the Interface of Neuroinflammation and Neuroprotection: Focus Onto the Glia. Frontiers in Cellular Neuroscience. Vol. 15:2021. Frontiers Media SA. [Cross Ref]

            26. Jaiswal Manoj Kumar. Calcium, mitochondria, and the pathogenesis of ALS: the good, the bad, and the ugly. Frontiers in Cellular Neuroscience. Vol. 7:2013. Frontiers Media SA. [Cross Ref]

            27. Zhou Yuxin, Zhen Yongqi, Wang Guan, Liu Bo. Deconvoluting the Complexity of Reactive Oxygen Species (ROS) in Neurodegenerative Diseases. Frontiers in Neuroanatomy. Vol. 16:2022. Frontiers Media SA. [Cross Ref]

            28. Jeon Yu-Mi, Kwon Younghwi, Lee Shinrye, Kim Hyung-Jun. Potential roles of the endoplasmic reticulum stress pathway in amyotrophic lateral sclerosis. Frontiers in Aging Neuroscience. Vol. 15:2023. Frontiers Media SA. [Cross Ref]

            29. Geloso Maria Concetta, Corvino Valentina, Marchese Elisa, Serrano Alessia, Michetti Fabrizio, D’Ambrosi Nadia. The Dual Role of Microglia in ALS: Mechanisms and Therapeutic Approaches. Frontiers in Aging Neuroscience. Vol. 9:2017. Frontiers Media SA. [Cross Ref]

            30. Weil Robert, Laplantine Emmanuel, Curic Shannel, Génin Pierre. Role of Optineurin in the Mitochondrial Dysfunction: Potential Implications in Neurodegenerative Diseases and Cancer. Frontiers in Immunology. Vol. 9:2018. Frontiers Media SA. [Cross Ref]

            31. Toth Reka P., Atkin Julie D.. Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma. Frontiers in Immunology. Vol. 9:2018. Frontiers Media SA. [Cross Ref]

            32. Liu Jia, Wang Fei. Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications. Frontiers in Immunology. Vol. 8:2017. Frontiers Media SA. [Cross Ref]

            33. Barker Roger A., Björklund Anders, Gash Don M., Whone Alan, Van Laar Amber, Kordower Jeffrey H., Bankiewicz Krystof, Kieburtz Karl, Saarma Mart, Booms Sigrid, Huttunen Henri J., Kells Adrian P., Fiandaca Massimo S., Stoessl A. Jon, Eidelberg David, Federoff Howard, Voutilainen Merja H., Dexter David T., Eberling Jamie, Brundin Patrik, Isaacs Lyndsey, Mursaleen Leah, Bresolin Eros, Carroll Camille, Coles Alasdair, Fiske Brian, Matthews Helen, Lungu Codrin, Wyse Richard K., Stott Simon, Lang Anthony E.. GDNF and Parkinson’s Disease: Where Next? A Summary from a Recent Workshop. Journal of Parkinson's Disease. Vol. 10(3):875–891. 2020. IOS Press. [Cross Ref]

            34. Fondell Elinor, O'Reilly Éilis J., Fitzgerald Kathryn C., Falcone Guido J., McCullough Marjorie L., Thun Michael J., Park Yikyung, Kolonel Laurence N., Ascherio Alberto. Non-steroidal anti-inflammatory drugs and amyotrophic lateral sclerosis: Results from five prospective cohort studies. Amyotrophic Lateral Sclerosis. Vol. 13(6):573–579. 2012. Informa UK Limited. [Cross Ref]

            35. Chiò Adriano, Logroscino Giancarlo, Hardiman Orla, Swingler Robert, Mitchell Douglas, Beghi Ettore, Traynor Bryan G., On Behalf of the Eurals Consortium. Prognostic factors in ALS: A critical review. Amyotrophic Lateral Sclerosis. Vol. 10(5-6):310–323. 2009. Informa UK Limited. [Cross Ref]

            36. Zhu Ling-Shuang, Wang Ding-Qi, Cui Ke, Liu Dan, Zhu Ling-Qiang. Emerging Perspectives on DNA Double-strand Breaks in Neurodegenerative Diseases. Current Neuropharmacology. Vol. 17(12):1146–1157. 2019. Bentham Science Publishers Ltd. [Cross Ref]

            37. Hovelso N., Sotty F., P. Montezinho L., S. Pinheiro P., F. Herrik K., Mork A.. Therapeutic Potential of Metabotropic Glutamate Receptor Modulators. Current Neuropharmacology. Vol. 10(1):12–48. 2012. Bentham Science Publishers Ltd. [Cross Ref]

            38. Ferrari R., Kapogiannis D., D. Huey E., Momeni P.. FTD and ALS: A Tale of Two Diseases. Current Alzheimer Research. Vol. 8(3):273–294. 2011. Bentham Science Publishers Ltd. [Cross Ref]

            39. Pehar Mariana, Harlan Benjamin A., Killoy Kelby M., Vargas Marcelo R.. Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis. Current Pharmaceutical Design. Vol. 23(33)2018. Bentham Science Publishers Ltd. [Cross Ref]

            40. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System. 2011. National Academies Press. [Cross Ref]

            41. Castedo Maria, Lafarge Antoine, Kroemer Guido. Poly(ADP-ribose) polymerase-1 and its ambiguous role in cellular life and death. Cell Stress. Vol. 7(1):1–6. 2023. Shared Science Publishers OG. [Cross Ref]

            42. Welch Gwyneth, Tsai Li‐Huei. Mechanisms of DNA damage‐mediated neurotoxicity in neurodegenerative disease. EMBO reports. Vol. 23(6)2022. Springer Science and Business Media LLC. [Cross Ref]

            43. Brandon Nicholas J., Jovanovic Jasmina N., Smart Trevor G., Moss Stephen J.. Receptor for Activated C Kinase-1 Facilitates Protein Kinase C-Dependent Phosphorylation and Functional Modulation of GABA<sub>A</sub>Receptors with the Activation of G-Protein-Coupled Receptors. The Journal of Neuroscience. Vol. 22(15):6353–6361. 2002. Society for Neuroscience. [Cross Ref]

            44. Foerster B.R., Callaghan B.C., Petrou M., Edden R.A.E., Chenevert T.L., Feldman E.L.. Decreased motor cortex γ-aminobutyric acid in amyotrophic lateral sclerosis. Neurology. Vol. 78(20):1596–1600. 2012. Ovid Technologies (Wolters Kluwer Health). [Cross Ref]

            45. Iacoangeli Alfredo, Al Khleifat Ahmad, Jones Ashley R., Sproviero William, Shatunov Aleksey, Opie-Martin Sarah, Morrison Karen E., Shaw Pamela J., Shaw Christopher E., Fogh Isabella, Dobson Richard J., Newhouse Stephen J., Al-Chalabi Ammar. C9orf72 intermediate expansions of 24–30 repeats are associated with ALS. Acta Neuropathologica Communications. Vol. 7(1)2019. Springer Science and Business Media LLC. [Cross Ref]

            46. Shanbhag Niraj M., Evans Mark D., Mao Wenjie, Nana Alissa L., Seeley William W., Adame Anthony, Rissman Robert A., Masliah Eliezer, Mucke Lennart. Early neuronal accumulation of DNA double strand breaks in Alzheimer’s disease. Acta Neuropathologica Communications. Vol. 7(1)2019. Springer Science and Business Media LLC. [Cross Ref]

            47. An Haiyan, Skelt Lucy, Notaro Antonietta, Highley J. Robin, Fox Archa H., La Bella Vincenzo, Buchman Vladimir L., Shelkovnikova Tatyana A.. ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles. Acta Neuropathologica Communications. Vol. 7(1)2019. Springer Science and Business Media LLC. [Cross Ref]

            48. McGurk L., Mojsilovic-Petrovic J., Van Deerlin V. M., Shorter J., Kalb R. G., Lee V. M., Trojanowski J. Q., Lee E. B., Bonini N. M.. Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis. Acta Neuropathologica Communications. Vol. 6(1)2018. Springer Science and Business Media LLC. [Cross Ref]

            49. Watanabe Seiji, Ageta-Ishihara Natsumi, Nagatsu Shinji, Takao Keizo, Komine Okiru, Endo Fumito, Miyakawa Tsuyoshi, Misawa Hidemi, Takahashi Ryosuke, Kinoshita Makoto, Yamanaka Koji. SIRT1 overexpression ameliorates a mouse model of SOD1-linked amyotrophic lateral sclerosis via HSF1/HSP70i chaperone system. Molecular Brain. Vol. 7(1)2014. Springer Science and Business Media LLC. [Cross Ref]

            50. Stoklund Dittlau Katarina, Terrie Lisanne, Baatsen Pieter, Kerstens Axelle, De Swert Lim, Janky Rekin’s, Corthout Nikky, Masrori Pegah, Van Damme Philip, Hyttel Poul, Meyer Morten, Thorrez Lieven, Freude Kristine, Van Den Bosch Ludo. FUS-ALS hiPSC-derived astrocytes impair human motor units through both gain-of-toxicity and loss-of-support mechanisms. Molecular Neurodegeneration. Vol. 18(1)2023. Springer Science and Business Media LLC. [Cross Ref]

            51. Bono Silvia, Feligioni Marco, Corbo Massimo. Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy. Molecular Neurodegeneration. Vol. 16(1)2021. Springer Science and Business Media LLC. [Cross Ref]

            52. Hartmaier Susan L., Rhodes Thomas, Cook Suzanne F., Schlusser Courtney, Chen Chao, Han Steve, Zach Neta, Murthy Venkatesha, Davé Shreya. Qualitative measures that assess functional disability and quality of life in ALS. Health and Quality of Life Outcomes. Vol. 20(1)2022. Springer Science and Business Media LLC. [Cross Ref]

            53. Park Jin-Mo, Park Donghwi, Kim Hyung-Jun, Park Jin-Sung. Long-term outcomes of edaravone in amyotrophic lateral sclerosis in South Korea: 72-week observational study. BMC Neurology. Vol. 22(1)2022. Springer Science and Business Media LLC. [Cross Ref]

            54. Luna Augustin, Aladjem Mirit I, Kohn Kurt W. SIRT1/PARP1 crosstalk: connecting DNA damage and metabolism. Genome Integrity. Vol. 4:2013. ScienceOpen. [Cross Ref]

            55. Panchabhai Tanmay S., Mireles Cabodevila Eduardo, Pioro Erik P., Wang Xiaofeng, Han Xiaozhen, Aboussouan Loutfi S.. Pattern of lung function decline in patients with amyotrophic lateral sclerosis: implications for timing of noninvasive ventilation. ERJ Open Research. Vol. 5(3):44–2019. 2019. European Respiratory Society (ERS). [Cross Ref]

            56. Dorst Johannes, Ludolph Albert C.. Non-invasive ventilation in amyotrophic lateral sclerosis. Therapeutic Advances in Neurological Disorders. Vol. 12:2019. SAGE Publications. [Cross Ref]

            57. Pozzi Silvia, Thammisetty Sai Sampath, Codron Philippe, Rahimian Reza, Plourde Karine Valérie, Soucy Geneviève, Bareil Christine, Phaneuf Daniel, Kriz Jasna, Gravel Claude, Julien Jean-Pierre. Virus-mediated delivery of antibody targeting TAR DNA-binding protein-43 mitigates associated neuropathology. Journal of Clinical Investigation. Vol. 129(4):1581–1595. 2019. American Society for Clinical Investigation. [Cross Ref]

            58. Pozzi Silvia, Codron Philippe, Soucy Geneviève, Renaud Laurence, Cordeau Pierre Junior, Dutta Kallol, Bareil Christine, Julien Jean-Pierre. Monoclonal full-length antibody against TAR DNA binding protein 43 reduces related proteinopathy in neurons. JCI Insight. Vol. 5(21)2020. American Society for Clinical Investigation. [Cross Ref]

            59. Kane Alice E., Sinclair David A.. Sirtuins and NAD <sup>+</sup> in the Development and Treatment of Metabolic and Cardiovascular Diseases. Circulation Research. Vol. 123(7):868–885. 2018. Ovid Technologies (Wolters Kluwer Health). [Cross Ref]

            60. Schielke Gerald P., Kupina Nancy C., Boxer Peter A., Bigge Christopher F., Welty Devin F.. The Neuroprotective Effect of the Novel AMPA Receptor Antagonist PD152247 (PNQX) in Temporary Focal Ischemia in the Rat. Stroke. Vol. 30(7):1472–1477. 1999. Ovid Technologies (Wolters Kluwer Health). [Cross Ref]

            61. Cunha-Oliveira Teresa, Montezinho Liliana, Mendes Catarina, Firuzi Omidreza, Saso Luciano, Oliveira Paulo J., Silva Filomena S. G.. Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention. Oxidative Medicine and Cellular Longevity. Vol. 2020:1–29. 2020. Hindawi Limited. [Cross Ref]

            62. Cheng Han, Gang Xiaokun, Liu Yujia, Wang Gang, Zhao Xue, Wang Guixia. Mitochondrial dysfunction plays a key role in the development of neurodegenerative diseases in diabetes. American Journal of Physiology-Endocrinology and Metabolism. Vol. 318(5)2020. American Physiological Society. [Cross Ref]

            63. Willemse Sean W, Harley Peter, van Eijk Ruben P A, Demaegd Koen C, Zelina Pavol, Pasterkamp R Jeroen, van Damme Philip, Ingre Caroline, van Rheenen Wouter, Veldink Jan H, Kiernan Matthew C, Al-Chalabi Ammar, van den Berg Leonard H, Fratta Pietro, van Es Michael A. <i>UNC13A</i>in amyotrophic lateral sclerosis: from genetic association to therapeutic target. Journal of Neurology, Neurosurgery &amp; Psychiatry. Vol. 94(8):649–656. 2023. BMJ. [Cross Ref]

            64. Nolan Matthew, Barbagallo Paola, Turner Martin R, Keogh Michael John, Chinnery Patrick F, Talbot Kevin, Ansorge Olaf. Isolated homozygous R217X <i>OPTN</i> mutation causes knock-out of functional C-terminal optineurin domains and associated oligodendrogliopathy-dominant ALS–TDP. Journal of Neurology, Neurosurgery &amp; Psychiatry. Vol. 92(9):1022–1024. 2021. BMJ. [Cross Ref]

            65. de Boer Eva Maria Johanna, Orie Viyanti K, Williams Timothy, Baker Mark R, De Oliveira Hugo M, Polvikoski Tuomo, Silsby Matthew, Menon Parvathi, van den Bos Mehdi, Halliday Glenda M, van den Berg Leonard H, Van Den Bosch Ludo, van Damme Philip, Kiernan Matthew C, van Es Michael A, Vucic Steve. TDP-43 proteinopathies: a new wave of neurodegenerative diseases. Journal of Neurology, Neurosurgery &amp; Psychiatry. Vol. 92(1):86–95. 2021. BMJ. [Cross Ref]

            66. Czaplinski A. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. Journal of Neurology, Neurosurgery &amp; Psychiatry. Vol. 77(3):390–392. 2005. BMJ. [Cross Ref]

            67. Welch Gwyneth M., Boix Carles A., Schmauch Eloi, Davila-Velderrain Jose, Victor Matheus B., Dileep Vishnu, Bozzelli P. Lorenzo, Su Qiao, Cheng Jemmie D., Lee Audrey, Leary Noelle S., Pfenning Andreas R., Kellis Manolis, Tsai Li-Huei. Neurons burdened by DNA double-strand breaks incite microglia activation through antiviral-like signaling in neurodegeneration. Science Advances. Vol. 8(39)2022. American Association for the Advancement of Science (AAAS). [Cross Ref]

            68. Kuhle J., Lindberg R. L. P., Regeniter A., Mehling M., Steck A. J., Kappos L., Czaplinski A.. Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. European Journal of Neurology. Vol. 16(6):771–774. 2009. Wiley. [Cross Ref]

            69. Jubin T., Kadam A., Jariwala M., Bhatt S., Sutariya S., Gani A.R., Gautam S., Begum R.. The <scp>PARP</scp> family: insights into functional aspects of poly (<scp>ADP</scp>‐ribose) polymerase‐1 in cell growth and survival. Cell Proliferation. Vol. 49(4):421–437. 2016. Wiley. [Cross Ref]

            70. Wang Yan, Xu Erin, Musich Phillip R., Lin Fang. Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure. CNS Neuroscience &amp; Therapeutics. Vol. 25(7):816–824. 2019. Wiley. [Cross Ref]

            71. Dorst Johannes, Behrendt Georg, Ludolph Albert C.. Non-invasive ventilation and hypercapnia-associated symptoms in amyotrophic lateral sclerosis. Acta Neurologica Scandinavica. Vol. 139(2):128–134. 2019. Hindawi Limited. [Cross Ref]

            72. Herskovits Adrianna Z., Hunter Tegan A., Maxwell Nicholas, Pereira Katherine, Whittaker Charles A., Valdez Gregorio, Guarente Leonard P.. SIRT1 deacetylase in aging‐induced neuromuscular degeneration and amyotrophic lateral sclerosis. Aging Cell. Vol. 17(6)2018. Wiley. [Cross Ref]

            73. Cohen Michael S.. Interplay between compartmentalized NAD<sup>+</sup> synthesis and consumption: a focus on the PARP family. Genes &amp; Development. Vol. 34(5-6):254–262. 2020. Cold Spring Harbor Laboratory. [Cross Ref]

            74. Gijselinck Ilse, Cruts Marc, Van Broeckhoven Christine. The Genetics of<i>C9orf72</i>Expansions. Cold Spring Harbor Perspectives in Medicine. Vol. 8(4)2018. Cold Spring Harbor Laboratory. [Cross Ref]

            75. Mackenzie Ian R.A., Neumann Manuela. Fused in Sarcoma Neuropathology in Neurodegenerative Disease. Cold Spring Harbor Perspectives in Medicine. Vol. 7(12)2017. Cold Spring Harbor Laboratory. [Cross Ref]

            76. Seddighi Sahba, Qi Yue A., Brown Anna-Leigh, Wilkins Oscar G., Bereda Colleen, Belair Cedric, Zhang Yongjie, Prudencio Mercedes, Keuss Matthew J, Khandeshi Aditya, Pickles Sarah, Hill Sarah E., Hawrot James, Ramos Daniel M., Yuan Hebao, Roberts Jessica, Sacramento Erika Kelmer, Shah Syed I., Nalls Mike A., Colon-Mercado Jenn, Reyes Joel F., Ryan Veronica H., Nelson Matthew P., Cook Casey, Li Ziyi, Screven Laurel, Kwan Justin Y, Shantaraman Anantharaman, Ping Lingyan, Koike Yuka, Oskarsson Björn, Staff Nathan, Duong Duc M., Ahmed Aisha, Secrier Maria, Ule Jerneg, Jacobson Steven, Rohrer Jonathan, Malaspina Andrea, Glass Jonathan D., Ori Alessandro, Seyfried Nicholas T., Maragkakis Manolis, Petrucelli Leonard, Fratta Pietro, Ward Michael E.. Mis-spliced transcripts generate<i>de novo</i>proteins in TDP-43-related ALS/FTD. Cold Spring Harbor Laboratory. [Cross Ref]

            77. Liu Chao, Vyas Aditi, Kassab Muzaffer A., Singh Anup K., Yu Xiaochun. The role of poly ADP-ribosylation in the first wave of DNA damage response. Nucleic Acids Research. Vol. 45(14):8129–8141. 2017. Oxford University Press (OUP). [Cross Ref]

            78. Reber Julia M, Mangerich Aswin. Why structure and chain length matter: on the biological significance underlying the structural heterogeneity of poly(ADP-ribose). Nucleic Acids Research. Vol. 49(15):8432–8448. 2021. Oxford University Press (OUP). [Cross Ref]

            79. Russo Arianna, Scardigli Raffaella, La Regina Federico, Murray Melissa E., Romano Nicla, Dickson Dennis W., Wolozin Benjamin, Cattaneo Antonino, Ceci Marcello. Increased cytoplasmic TDP-43 reduces global protein synthesis by interacting with RACK1 on polyribosomes. Human Molecular Genetics. Vol. 26(8):1407–1418. 2017. Oxford University Press (OUP). [Cross Ref]

            80. Koretsky Mathew J, Alvarado Chelsea, Makarious Mary B, Vitale Dan, Levine Kristin, Bandres-Ciga Sara, Dadu Anant, Scholz Sonja W, Sargent Lana, Faghri Faraz, Iwaki Hirotaka, Blauwendraat Cornelis, Singleton Andrew, Nalls Mike, Leonard Hampton. Genetic risk factor clustering within and across neurodegenerative diseases. Brain. Vol. 146(11):4486–4494. 2023. Oxford University Press (OUP). [Cross Ref]

            81. Chapman Laura, Cooper-Knock Johnathan, Shaw Pamela J. Physical activity as an exogenous risk factor for amyotrophic lateral sclerosis: a review of the evidence. Brain. Vol. 146(5):1745–1757. 2023. Oxford University Press (OUP). [Cross Ref]

            82. Murata Michael M., Kong Xiangduo, Moncada Emmanuel, Chen Yumay, Imamura Hiromi, Wang Ping, Berns Michael W., Yokomori Kyoko, Digman Michelle A.. NAD+ consumption by PARP1 in response to DNA damage triggers metabolic shift critical for damaged cell survival. Molecular Biology of the Cell. Vol. 30(20):2584–2597. 2019. American Society for Cell Biology (ASCB). [Cross Ref]

            83. Braidy Nady, Berg Jade, Clement James, Khorshidi Fatemeh, Poljak Anne, Jayasena Tharusha, Grant Ross, Sachdev Perminder. Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes. Antioxidants &amp; Redox Signaling. Vol. 30(2):251–294. 2019. Mary Ann Liebert Inc. [Cross Ref]

            84. Massaad Cynthia A., Klann Eric. Reactive Oxygen Species in the Regulation of Synaptic Plasticity and Memory. Antioxidants &amp; Redox Signaling. Vol. 14(10):2013–2054. 2011. Mary Ann Liebert Inc. [Cross Ref]

            85. Goutman Stephen A., Boss Jonathan, Godwin Christopher, Mukherjee Bhramar, Feldman Eva L., Batterman Stuart A.. Occupational history associates with ALS survival and onset segment. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. Vol. 24(3-4):219–229. 2023. Informa UK Limited. [Cross Ref]

            86. Mehta Paul, Raymond Jaime, Punjani Reshma, Han Moon, Larson Theodore, Kaye Wendy, Nelson Lorene M., Topol Barbara, Muravov Oleg, Genson Corina, Horton D. Kevin. Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 2017. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. Vol. 24(1-2):108–116. 2023. Informa UK Limited. [Cross Ref]

            87. de la Rubia JosÉ E., Drehmer Eraci, Platero JosÉ L., Benlloch MarÍa, Caplliure-Llopis Jordi, Villaron-Casales Carlos, de Bernardo Nieves, AlarcÓn Jorge, Fuente Cristian, Carrera Sandra, Sancho David, GarcÍa-Pardo Pilar, Pascual Raquel, JuÁrez Marta, Cuerda-Ballester María, Forner Alfonso, Sancho-Castillo Sandra, Barrios Carlos, Obrador Elena, Marchio Patricia, Salvador Rosario, Holmes Holly E., Dellinger Ryan W., Guarente Leonard, Estrela José M.. Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. Vol. 20(1-2):115–122. 2019. Informa UK Limited. [Cross Ref]

            88. Mitra Joy, Guerrero Erika N., Hegde Pavana M., Liachko Nicole F., Wang Haibo, Vasquez Velmarini, Gao Junling, Pandey Arvind, Taylor J. Paul, Kraemer Brian C., Wu Ping, Boldogh Istvan, Garruto Ralph M., Mitra Sankar, Rao K. S., Hegde Muralidhar L.. Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects. Proceedings of the National Academy of Sciences. Vol. 116(10):4696–4705. 2019. Proceedings of the National Academy of Sciences. [Cross Ref]

            89. Gorbatyuk Marina. S., Knox Tessa, LaVail Matthew M., Gorbatyuk Oleg S., Noorwez Syed M., Hauswirth William W., Lin Jonathan H., Muzyczka Nicholas, Lewin Alfred S.. Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP/Grp78. Proceedings of the National Academy of Sciences. Vol. 107(13):5961–5966. 2010. Proceedings of the National Academy of Sciences. [Cross Ref]

            90. Miller Timothy M., Cudkowicz Merit E., Genge Angela, Shaw Pamela J., Sobue Gen, Bucelli Robert C., Chiò Adriano, Van Damme Philip, Ludolph Albert C., Glass Jonathan D., Andrews Jinsy A., Babu Suma, Benatar Michael, McDermott Christopher J., Cochrane Thos, Chary Sowmya, Chew Sheena, Zhu Han, Wu Fan, Nestorov Ivan, Graham Danielle, Sun Peng, McNeill Manjit, Fanning Laura, Ferguson Toby A., Fradette Stephanie. Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALS. New England Journal of Medicine. Vol. 387(12):1099–1110. 2022. Massachusetts Medical Society. [Cross Ref]

            91. Meyer Thomas. Amyotrophe Lateralsklerose (ALS) – Diagnose, Verlauf und neue Behandlungsoptionen. DMW - Deutsche Medizinische Wochenschrift. Vol. 146(24/25):1613–1618. 2021. Georg Thieme Verlag KG. [Cross Ref]

            92. Yoshioka Akira, Hardy Mattie, Younkin Donald P., Grinspan Judith B., Stern Janet L., Pleasure David. α‐Amino‐3‐Hydroxy‐5‐Methyl‐4‐Isoxazolepropionate (AMPA) Receptors Mediate Excitotoxicity in the Oligodendroglial Lineage. Journal of Neurochemistry. Vol. 64(6):2442–2448. 1995. Wiley. [Cross Ref]

            93. Asada-Utsugi Megumi, Uemura Kengo, Ayaki Takashi, T. Uemura Maiko, Minamiyama Sumio, Hikiami Ryota, Morimura Toshifumi, Shodai Akemi, Ueki Takatoshi, Takahashi Ryosuke, Kinoshita Ayae, Urushitani Makoto. Failure of DNA double-strand break repair by tau mediates Alzheimer’s disease pathology in vitro. Communications Biology. Vol. 5(1)2022. Springer Science and Business Media LLC. [Cross Ref]

            94. Segura Tomás, Medrano Ignacio H., Collazo Sergio, Maté Claudia, Sguera Carlo, Del Rio-Bermudez Carlos, Casero Hugo, Salcedo Ignacio, García-García Jorge, Alcahut-Rodríguez Cristian, Aquino José, Casadevall David, Donaire David, Marin-Corral Judith, Menke Sebastian, Polo Natalia, Taberna Miren. Symptoms timeline and outcomes in amyotrophic lateral sclerosis using artificial intelligence. Scientific Reports. Vol. 13(1)2023. Springer Science and Business Media LLC. [Cross Ref]

            95. Chang Min Cheol, Kwak Sang Gyu, Park Jin-Sung, Park Donghwi. The effectiveness of nonsteroidal anti-inflammatory drugs and acetaminophen in reduce the risk of amyotrophic lateral sclerosis? A meta-analysis. Scientific Reports. Vol. 10(1)2020. Springer Science and Business Media LLC. [Cross Ref]

            96. Kumar Senthil T., Nazarov Sergey, Porta Sílvia, Maharjan Niran, Cendrowska Urszula, Kabani Malek, Finamore Francesco, Xu Yan, Lee Virginia M.-Y., Lashuel Hilal A.. Seeding the aggregation of TDP-43 requires post-fibrillization proteolytic cleavage. Nature Neuroscience. Vol. 26(6):983–996. 2023. Springer Science and Business Media LLC. [Cross Ref]

            97. Sun Jichao, Roy Subhojit. Gene-based therapies for neurodegenerative diseases. Nature Neuroscience. Vol. 24(3):297–311. 2021. Springer Science and Business Media LLC. [Cross Ref]

            98. Klim Joseph R., Williams Luis A., Limone Francesco, Guerra San Juan Irune, Davis-Dusenbery Brandi N., Mordes Daniel A., Burberry Aaron, Steinbaugh Michael J., Gamage Kanchana K., Kirchner Rory, Moccia Rob, Cassel Seth H., Chen Kuchuan, Wainger Brian J., Woolf Clifford J., Eggan Kevin. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nature Neuroscience. Vol. 22(2):167–179. 2019. Springer Science and Business Media LLC. [Cross Ref]

            99. Melamed Ze’ev, López-Erauskin Jone, Baughn Michael W., Zhang Ouyang, Drenner Kevin, Sun Ying, Freyermuth Fernande, McMahon Moira A., Beccari Melinda S., Artates Jon W., Ohkubo Takuya, Rodriguez Maria, Lin Nianwei, Wu Dongmei, Bennett C. Frank, Rigo Frank, Da Cruz Sandrine, Ravits John, Lagier-Tourenne Clotilde, Cleveland Don W.. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nature Neuroscience. Vol. 22(2):180–190. 2019. Springer Science and Business Media LLC. [Cross Ref]

            100. Brown Anna-Leigh, Wilkins Oscar G., Keuss Matthew J., Hill Sarah E., Zanovello Matteo, Lee Weaverly Colleen, Bampton Alexander, Lee Flora C. Y., Masino Laura, Qi Yue A., Bryce-Smith Sam, Gatt Ariana, Hallegger Martina, Fagegaltier Delphine, Phatnani Hemali, Phatnani Hemali, Kwan Justin, Sareen Dhruv, Broach James R., Simmons Zachary, Arcila-Londono Ximena, Lee Edward B., Van Deerlin Vivianna M., Shneider Neil A., Fraenkel Ernest, Ostrow Lyle W., Baas Frank, Zaitlen Noah, Berry James D., Malaspina Andrea, Fratta Pietro, Cox Gregory A., Thompson Leslie M., Finkbeiner Steve, Dardiotis Efthimios, Miller Timothy M., Chandran Siddharthan, Pal Suvankar, Hornstein Eran, MacGowan Daniel J., Heiman-Patterson Terry, Hammell Molly G., Patsopoulos Nikolaos. A., Butovsky Oleg, Dubnau Joshua, Nath Avindra, Bowser Robert, Harms Matthew, Aronica Eleonora, Poss Mary, Phillips-Cremins Jennifer, Crary John, Atassi Nazem, Lange Dale J., Adams Darius J., Stefanis Leonidas, Gotkine Marc, Baloh Robert H., Babu Suma, Raj Towfique, Paganoni Sabrina, Shalem Ophir, Smith Colin, Zhang Bin, Harris Brent, Broce Iris, Drory Vivian, Ravits John, McMillan Corey, Menon Vilas, Wu Lani, Altschuler Steven, Lerner Yossef, Sattler Rita, Van Keuren-Jensen Kendall, Rozenblatt-Rosen Orit, Lindblad-Toh Kerstin, Nicholson Katharine, Gregersen Peter, Lee Jeong-Ho, Koks Sulev, Muljo Stephen, Newcombe Jia, Gustavsson Emil K., Seddighi Sahba, Reyes Joel F., Coon Steven L., Ramos Daniel, Schiavo Giampietro, Fisher Elizabeth M. C., Raj Towfique, Secrier Maria, Lashley Tammaryn, Ule Jernej, Buratti Emanuele, Humphrey Jack, Ward Michael E., Fratta Pietro. TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature. Vol. 603(7899):131–137. 2022. Springer Science and Business Media LLC. [Cross Ref]

            101. Ziff Oliver J., Neeves Jacob, Mitchell Jamie, Tyzack Giulia, Martinez-Ruiz Carlos, Luisier Raphaelle, Chakrabarti Anob M., McGranahan Nicholas, Litchfield Kevin, Boulton Simon J., Al-Chalabi Ammar, Kelly Gavin, Humphrey Jack, Patani Rickie. Integrated transcriptome landscape of ALS identifies genome instability linked to TDP-43 pathology. Nature Communications. Vol. 14(1)2023. Springer Science and Business Media LLC. [Cross Ref]

            102. Yang Liang, Shen Junfeng, Liu Chunhua, Kuang Zhonghua, Tang Yong, Qian Zhengjiang, Guan Min, Yang Yongfeng, Zhan Yang, Li Nan, Li Xiang. Nicotine rebalances NAD+ homeostasis and improves aging-related symptoms in male mice by enhancing NAMPT activity. Nature Communications. Vol. 14(1)2023. Springer Science and Business Media LLC. [Cross Ref]

            103. Bernard-Marissal Nathalie, Chrast Roman, Schneider Bernard L.. Endoplasmic reticulum and mitochondria in diseases of motor and sensory neurons: a broken relationship? Cell Death &amp; Disease. Vol. 9(3)2018. Springer Science and Business Media LLC. [Cross Ref]

            104. Chen-Plotkin Alice S., Lee Virginia M.-Y., Trojanowski John Q.. TAR DNA-binding protein 43 in neurodegenerative disease. Nature Reviews Neurology. Vol. 6(4):211–220. 2010. Springer Science and Business Media LLC. [Cross Ref]

            105. Nagai Makiko, Re Diane B, Nagata Tetsuya, Chalazonitis Alcmène, Jessell Thomas M, Wichterle Hynek, Przedborski Serge. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nature Neuroscience. Vol. 10(5):615–622. 2007. Springer Science and Business Media LLC. [Cross Ref]

            106. Maruyama Hirofumi, Morino Hiroyuki, Ito Hidefumi, Izumi Yuishin, Kato Hidemasa, Watanabe Yasuhito, Kinoshita Yoshimi, Kamada Masaki, Nodera Hiroyuki, Suzuki Hidenori, Komure Osamu, Matsuura Shinya, Kobatake Keitaro, Morimoto Nobutoshi, Abe Koji, Suzuki Naoki, Aoki Masashi, Kawata Akihiro, Hirai Takeshi, Kato Takeo, Ogasawara Kazumasa, Hirano Asao, Takumi Toru, Kusaka Hirofumi, Hagiwara Koichi, Kaji Ryuji, Kawakami Hideshi. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. Vol. 465(7295):223–226. 2010. Springer Science and Business Media LLC. [Cross Ref]

            107. Dalkara Deniz, Kolstad Kathleen D, Guerin Karen I, Hoffmann Natalie V, Visel Meike, Klimczak Ryan R, Schaffer David V, Flannery John G. AAV Mediated GDNF Secretion From Retinal Glia Slows Down Retinal Degeneration in a Rat Model of Retinitis Pigmentosa. Molecular Therapy. Vol. 19(9):1602–1608. 2011. Elsevier BV. [Cross Ref]

            108. Pasinetti Giulio Maria, Bilski Amanda E, Zhao Wei. Sirtuins as therapeutic targets of ALS. Cell Research. Vol. 23(9):1073–1074. 2013. Springer Science and Business Media LLC. [Cross Ref]

            109. Kawaguchi Tetsuya, Rollins Matthew G., Moinpour Mahta, Morera Andres A., Ebmeier Christopher C., Old William M., Schwartz Jacob C.. Changes to the TDP-43 and FUS Interactomes Induced by DNA Damage. Journal of Proteome Research. Vol. 19(1):360–370. 2020. American Chemical Society (ACS). [Cross Ref]

            110. Fang Ton, Al Khleifat Ahmad, Meurgey Jacques-Henri, Jones Ashley, Leigh P Nigel, Bensimon Gilbert, Al-Chalabi Ammar. Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study. The Lancet Neurology. Vol. 17(5):416–422. 2018. Elsevier BV. [Cross Ref]

            111. Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study. The Lancet Neurology. Vol. 14(7):702–709. 2015. Elsevier BV. [Cross Ref]

            112. Betz Andrea, Thakur Pratima, Junge Harald J., Ashery Uri, Rhee Jeong-Seop, Scheuss Volker, Rosenmund Christian, Rettig Jens, Brose Nils. Functional Interaction of the Active Zone Proteins Munc13-1 and RIM1 in Synaptic Vesicle Priming. Neuron. Vol. 30(1):183–196. 2001. Elsevier BV. [Cross Ref]

            113. Linares Gabriel R., Li Yichen, Chang Wen-Hsuan, Rubin-Sigler Jasper, Mendonca Stacee, Hong Sarah, Eoh Yunsun, Guo Wenxuan, Huang Yi-Hsuan, Chang Jonathan, Tu Sharon, Dorjsuren Nomongo, Santana Manuel, Hung Shu-Ting, Yu Johnny, Perez Joscany, Chickering Michael, Cheng Tze-Yuan, Huang Chi-Chou, Lee Shih-Jong James, Deng Hao-Jen, Bach Kieu-Tram, Gray Kamden, Subramanyam Vishvak, Rosenfeld Jeffrey, Alworth Samuel V., Goodarzi Hani, Ichida Justin K.. SYF2 suppression mitigates neurodegeneration in models of diverse forms of ALS. Cell Stem Cell. Vol. 30(2)2023. Elsevier BV. [Cross Ref]

            114. Minegishi Yuriko, Nakayama Mao, Iejima Daisuke, Kawase Kazuhide, Iwata Takeshi. Significance of optineurin mutations in glaucoma and other diseases. Progress in Retinal and Eye Research. Vol. 55:149–181. 2016. Elsevier BV. [Cross Ref]

            115. Rosenfeld Jeffrey, Ellis Amy. Nutrition and Dietary Supplements in Motor Neuron Disease. Physical Medicine and Rehabilitation Clinics of North America. Vol. 19(3):573–589. 2008. Elsevier BV. [Cross Ref]

            116. Herskovits A. Zara, Guarente Leonard. SIRT1 in Neurodevelopment and Brain Senescence. Neuron. Vol. 81(3):471–483. 2014. Elsevier BV. [Cross Ref]

            117. Kurashige Takashi, Kuramochi Masahito, Ohsawa Ryosuke, Yamashita Yui, Shioi Go, Morino Hiroyuki, Kamada Masaki, Ayaki Takashi, Ito Hidefumi, Sotomaru Yusuke, Maruyama Hirofumi, Kawakami Hideshi. Optineurin defects cause TDP43-pathology with autophagic vacuolar formation. Neurobiology of Disease. Vol. 148:2021. Elsevier BV. [Cross Ref]

            118. SCHUTZ B. Imbalanced excitatory to inhibitory synaptic input precedes motor neuron degeneration in an animal model of amyotrophic lateral sclerosis. Neurobiology of Disease. Vol. 20(1):131–140. 2005. Elsevier BV. [Cross Ref]

            119. Prokhorova Evgeniia, Agnew Thomas, Wondisford Anne R., Tellier Michael, Kaminski Nicole, Beijer Danique, Holder James, Groslambert Josephine, Suskiewicz Marcin J., Zhu Kang, Reber Julia M., Krassnig Sarah C., Palazzo Luca, Murphy Shona, Nielsen Michael L., Mangerich Aswin, Ahel Dragana, Baets Jonathan, O’Sullivan Roderick J., Ahel Ivan. Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human disease. Molecular Cell. Vol. 81(12)2021. Elsevier BV. [Cross Ref]

            120. Wu Yuanbo, Chen Meiqiao, Jiang Jielong. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling. Mitochondrion. Vol. 49:35–45. 2019. Elsevier BV. [Cross Ref]

            121. Dormann Dorothee, Haass Christian. Fused in sarcoma (FUS): An oncogene goes awry in neurodegeneration. Molecular and Cellular Neuroscience. Vol. 56:475–486. 2013. Elsevier BV. [Cross Ref]

            122. Kamalian Aida, Foroughmand Iman, Koski Lassi, Darvish Mahtab, Saghazadeh Amene, Kamalian Amirhossein, Razavi Seyedeh Zahra Emami, Abdi Siamak, Dehgolan Shahram Rahimi, Fotouhi Akbar, Roos Per M.. Metal concentrations in cerebrospinal fluid, blood, serum, plasma, hair, and nails in amyotrophic lateral sclerosis: A systematic review and meta-analysis. Journal of Trace Elements in Medicine and Biology. Vol. 78:2023. Elsevier BV. [Cross Ref]

            123. Ruszkiewicz Joanna A., Bürkle Alexander, Mangerich Aswin. Fueling genome maintenance: On the versatile roles of NAD+ in preserving DNA integrity. Journal of Biological Chemistry. Vol. 298(6)2022. Elsevier BV. [Cross Ref]

            124. Jiménez-Villegas J., Ferraiuolo L., Mead R.J., Shaw P.J., Cuadrado A., Rojo A.I.. NRF2 as a therapeutic opportunity to impact in the molecular roadmap of ALS. Free Radical Biology and Medicine. Vol. 173:125–141. 2021. Elsevier BV. [Cross Ref]

            125. Miquel Ernesto, Cassina Adriana, Martínez-Palma Laura, Souza José M., Bolatto Carmen, Rodríguez-Bottero Sebastián, Logan Angela, Smith Robin A.J., Murphy Michael P., Barbeito Luis, Radi Rafael, Cassina Patricia. Neuroprotective effects of the mitochondria-targeted antioxidant MitoQ in a model of inherited amyotrophic lateral sclerosis. Free Radical Biology and Medicine. Vol. 70:204–213. 2014. Elsevier BV. [Cross Ref]

            126. Julian Thomas H, Glascow Nicholas, Barry A Dylan Fisher, Moll Tobias, Harvey Calum, Klimentidis Yann C, Newell Michelle, Zhang Sai, Snyder Michael P, Cooper-Knock Johnathan, Shaw Pamela J. Physical exercise is a risk factor for amyotrophic lateral sclerosis: Convergent evidence from Mendelian randomisation, transcriptomics and risk genotypes. EBioMedicine. Vol. 68:2021. Elsevier BV. [Cross Ref]

            127. Pluth Janice M., Yamazaki Vikky, Cooper Brian A., Rydberg Bjorn E., Kirchgessner Cordula U., Cooper Priscilla K.. DNA double-strand break and chromosomal rejoining defects with misrejoining in Nijmegen breakage syndrome cells. DNA Repair. Vol. 7(1):108–118. 2008. Elsevier BV. [Cross Ref]

            128. Liu Ling, Su Xiaoyang, Quinn William J., Hui Sheng, Krukenberg Kristin, Frederick David W., Redpath Philip, Zhan Le, Chellappa Karthikeyani, White Eileen, Migaud Marie, Mitchison Timothy J., Baur Joseph A., Rabinowitz Joshua D.. Quantitative Analysis of NAD Synthesis-Breakdown Fluxes. Cell Metabolism. Vol. 27(5)2018. Elsevier BV. [Cross Ref]

            129. Krus Kelsey L., Strickland Amy, Yamada Yurie, Devault Laura, Schmidt Robert E., Bloom A. Joseph, Milbrandt Jeffrey, DiAntonio Aaron. Loss of Stathmin-2, a hallmark of TDP-43-associated ALS, causes motor neuropathy. Cell Reports. Vol. 39(13)2022. Elsevier BV. [Cross Ref]

            130. Hung Shu-Ting, Linares Gabriel R., Chang Wen-Hsuan, Eoh Yunsun, Krishnan Gopinath, Mendonca Stacee, Hong Sarah, Shi Yingxiao, Santana Manuel, Kueth Chuol, Macklin-Isquierdo Samantha, Perry Sarah, Duhaime Sarah, Maios Claudia, Chang Jonathan, Perez Joscany, Couto Alexander, Lai Jesse, Li Yichen, Alworth Samuel V., Hendricks Eric, Wang Yaoming, Zlokovic Berislav V., Dickman Dion K., Parker J. Alex, Zarnescu Daniela C., Gao Fen-Biao, Ichida Justin K.. PIKFYVE inhibition mitigates disease in models of diverse forms of ALS. Cell. Vol. 186(4)2023. Elsevier BV. [Cross Ref]

            131. Grosskreutz Julian, Van Den Bosch Ludo, Keller Bernhard U.. Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium. Vol. 47(2):165–174. 2010. Elsevier BV. [Cross Ref]

            132. Brown Dean G., Shorter James, Wobst Heike J.. Emerging small-molecule therapeutic approaches for amyotrophic lateral sclerosis and frontotemporal dementia. Bioorganic &amp; Medicinal Chemistry Letters. Vol. 30(4)2020. Elsevier BV. [Cross Ref]

            133. Swamy Shobha M., Rajasekaran Namakkal S., Thannickal Victor J.. Nuclear Factor–Erythroid-2–Related Factor 2 in Aging and Lung Fibrosis. The American Journal of Pathology. Vol. 186(7):1712–1723. 2016. Elsevier BV. [Cross Ref]

            134. Hayden C. D., Murphy B. P., Hardiman O., Murray D.. Measurement of upper limb function in ALS: a structured review of current methods and future directions. Journal of Neurology. Vol. 269(8):4089–4101. 2022. Springer Science and Business Media LLC. [Cross Ref]

            135. Urwin Hazel, Josephs Keith A., Rohrer Jonathan D., Mackenzie Ian R., Neumann Manuela, Authier Astrid, Seelaar Harro, Van Swieten John C., Brown Jeremy M., Johannsen Peter, Nielsen Jorgen E., Holm Ida E., Dickson Dennis W., Rademakers Rosa, Graff-Radford Neill R., Parisi Joseph E., Petersen Ronald C., Hatanpaa Kimmo J., White III Charles L., Weiner Myron F., Geser Felix, Van Deerlin Vivianna M., Trojanowski John Q., Miller Bruce L., Seeley William W., van der Zee Julie, Kumar-Singh Samir, Engelborghs Sebastiaan, De Deyn Peter P., Van Broeckhoven Christine, Bigio Eileen H., Deng Han-Xiang, Halliday Glenda M., Kril Jillian J., Munoz David G., Mann David M., Pickering-Brown Stuart M., Doodeman Valerie, Adamson Gary, Ghazi-Noori Shabnam, Fisher Elizabeth M. C., Holton Janice L., Revesz Tamas, Rossor Martin N., Collinge John, Mead Simon, Isaacs Adrian M.. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathologica. Vol. 120(1):33–41. 2010. Springer Science and Business Media LLC. [Cross Ref]

            136. Cercillieux Angelique, Ciarlo Eleonora, Canto Carles. Balancing NAD+ deficits with nicotinamide riboside: therapeutic possibilities and limitations. Cellular and Molecular Life Sciences. Vol. 79(8)2022. Springer Science and Business Media LLC. [Cross Ref]

            137. Kolb Stephen J., Sutton Scott, Schoenberg Daniel R.. RNA processing defects associated with diseases of the motor neuron. Muscle &amp; Nerve. Vol. 41(1):5–17. 2010. Wiley. [Cross Ref]

            138. Cannan Wendy J., Pederson David S.. Mechanisms and Consequences of Double‐Strand DNA Break Formation in Chromatin. Journal of Cellular Physiology. Vol. 231(1):3–14. 2016. Wiley. [Cross Ref]

            139. Rubin Camelia Iancu, Atweh George F.. The role of stathmin in the regulation of the cell cycle. Journal of Cellular Biochemistry. Vol. 93(2):242–250. 2004. Wiley. [Cross Ref]

            140. Abel Olubunmi, Powell John F, Andersen Peter M., Al-Chalabi Ammar. ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics. Human Mutation. Vol. 33(9):1345–1351. 2012. Hindawi Limited. [Cross Ref]

            141. Gao Lan, Giannousis Peter, Thoolen Martin, Kaushik Diksha, Latham Joey, Tansy Aaron, Ma Jiyuan, Johnston Mayzie, Dali Mandar, Golden Lee, Klein Matthew, Kong Ronald, Trimmer Jeffrey. First‐in‐Human Studies of Pharmacokinetics and Safety of Utreloxastat (PTC857), a Novel 15‐Lipooxygenase Inhibitor for the Treatment of Amyotrophic Lateral Sclerosis. Clinical Pharmacology in Drug Development. Vol. 12(2):141–151. 2023. Wiley. [Cross Ref]

            142. Lang Anthony E., Gill Steven, Patel Nik K., Lozano Andres, Nutt John G., Penn Richard, Brooks David J., Hotton Gary, Moro Elena, Heywood Peter, Brodsky Matthew A., Burchiel Kim, Kelly Patrick, Dalvi Arif, Scott Burton, Stacy Mark, Turner Dennis, Wooten V. G. Frederich, Elias William J., Laws Edward R., Dhawan Vijay, Stoessl A. Jon, Matcham James, Coffey Robert J., Traub Michael. Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease. Annals of Neurology. Vol. 59(3):459–466. 2006. Wiley. [Cross Ref]

            143. Ticozzi N., Vance C., LeClerc A.L., Keagle P., Glass J.D., McKenna‐Yasek D., Sapp P.C., Silani V., Bosco D.A., Shaw C.E., Brown R.H., Landers J.E.. Mutational analysis reveals the <i>FUS</i> homolog <i>TAF15</i> as a candidate gene for familial amyotrophic lateral sclerosis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. Vol. 156(3):285–290. 2011. Wiley. [Cross Ref]

            144. Diana Andrea, Pillai Rita, Bongioanni Paolo, O'Keeffe Aidan G, Miller Robert G, Moore Dan H. Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews. Vol. 2017(1)2017. Wiley. [Cross Ref]

            145. Deng Han-Xiang. Differential Involvement of Optineurin in Amyotrophic Lateral Sclerosis With or Without &lt;emph type="ital"&gt;SOD1&lt;/emph&gt; Mutations. Archives of Neurology. Vol. 68(8)2011. American Medical Association (AMA). [Cross Ref]

            Comments

            Comment on this article